## NEM: Newmont Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 3.7% below STRENGTH zone (4.0-10.0%); PEG 1.91 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($87.43)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Does Newmont’s 145% 2025 Rally Match Its Gold Fueled Earnings and Cash Flow Outlook?**
- Source: Simply Wall Street | 20251210T034351 | Bullish | Relevance: 99%
-  Newmont (NYSE: NEM) has seen a significant 145.2% rally year-to-date, with strong tailwinds from higher gold prices. A Discounted Cash Flow analysis suggests an intrinsic value of $124.59 per share, indicating a 24.5% discount to the current market price, while its current P/E ratio of 14.3x is below industry and peer averages, suggesting it may still be undervalued based on its fundamentals. The article encourages investors to utilize "Narratives" on Simply Wall St's community page to personalize valuation models based on individual outlooks for the company.

**2. Newmont Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251209T163000 | Bullish | Relevance: 98%
-  Newmont Corp. (NEM) saw its stock rally 5.72% to $94.09 on Tuesday, significantly outperforming the broader market during a dismal trading session. This rise broke a two-day losing streak for the company, even as the S&P 500 Index and Dow Jones Industrial Average experienced declines.

**3. BNP Paribas Exane Downgrades Newmont Corporation (NEM) to Neutral from Outperform**
- Source: Finviz | 20251208T235200 | Neutral | Relevance: 98%
-  BNP Paribas Exane downgraded Newmont Corporation (NEM) to Neutral from Outperform on December 5, setting a target price of $97, citing momentum in the copper sector for 2026 and shifting preferences in gold. This contrasts with recent Buy ratings and higher price targets from UBS analysts. Newmont reported strong Q3 2025 performance with record free cash flow and achieved commercial production at its Ahafo North project.

**4. Newmont Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251209T163000 | Bullish | Relevance: 98%
-  Newmont Corp. (NEM) shares rallied 5.72% to $94.09 on Tuesday, contrasting with a general market downturn where the S&P 500 Index and Dow Jones Industrial Average experienced declines. This strong performance ended a two-day losing streak for Newmont. The article highlights the company's outperformance relative to the broader market and its competitors on a challenging trading day.

**5. BNP Paribas Exane Downgrades Newmont Corporation (NEM) to Neutral from Outperform**
- Source: Yahoo Finance | 20251208T235200 | Neutral | Relevance: 97%
-  BNP Paribas Exane downgraded Newmont Corporation (NEM) to Neutral from Outperform, setting a $97 price target, citing increasing momentum in the copper sector and a shift towards aluminum while maintaining a constructive view on gold. Conversely, UBS analysts reiterated Buy ratings on NEM, with price targets of A$190.00 and $125 respectively, anticipating continued gold demand fueled by central banks and investors through 2026. Newmont reported strong Q3 2025 results, including record free cash flow, and announced commercial production at its Ahafo North project in Ghana, expected to contribute significantly to gold output.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | UBS | $125 | $106 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 11.2% (+3.4%)
- State Street Corpora: 4.5% (-0.3%)
- Geode Capital Manage: 2.4% (+3.9%)
- Van Eck Associates C: 2.2% (-42.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +3.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.91 elevated, pricing in significant growth expectations. Forward P/E 12.6x attractive for 20% earnings growth. Quality metrics strong (ROE 23%, ROA 10%, margin 33%). Balance sheet: strong liquidity (2.0x), $1.6B free cash flow. Analyst sentiment positive (1 raises, avg +18%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $103.4B |
| Beta | 0.43 |
| 52W Range | $36.86 - $98.58 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.91 |
| Forward P/E | 12.6 |
| Current P/E | 15.0 |
| YoY Growth | 19.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.7% to 3.7% (+3.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 at 3.6% confirms short-term momentum alignment. AM_20 at 5.9% shows strong absolute momentum above own 20MA. Outperforming sector by 6.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.71% (CS: 79) | Neutral |
| RSI_14 | 61.6 | Neutral |
| MACD Histogram | 0.35 | Bullish |
| vs SMA20 | 1.059x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 1.428x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $94.09
- **Stop Loss:** $87.43 (7.1% risk)
- **Target:** $100.75 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $7,056.75
- **Portfolio %:** 7.06%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-19 (Est: $1.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.44 | $1.71 | +18.8% |
| 2025Q2 | $1.16 | $1.43 | +22.9% |
| 2025Q1 | $0.91 | $1.25 | +37.1% |
| 2024Q4 | $1.03 | $1.40 | +35.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*